Literature DB >> 21703848

The contribution of chest CT-scan at diagnosis in children with unilateral Wilms' tumour. Results of the SIOP 2001 study.

Anne M J B Smets1, Harm van Tinteren, Christophe Bergeron, Beatriz De Camargo, Norbert Graf, Kathy Pritchard-Jones, Jan de Kraker.   

Abstract

BACKGROUND: The SIOP 2001 nephroblastoma study hypothesised that patients with 'CT-only' pulmonary nodules would have the same outcome as patients with localised disease of same stage and histology. PATIENTS: Unilateral Wilms' tumour (WT) patients, who had chest CT scans at diagnosis showing any sized pulmonary nodules undetected on chest X-ray, between November 2001 and November 2009, were selected from the SIOP 2001 database.
RESULTS: Among 2532 WT patients, 103 unilateral nephroblastoma patients with CT-only lung lesions were found. Thirty-seven patients received preoperative treatment according to the localised-disease protocol, and 66 according to the metastatic-disease protocol. The 3-year event-free survival (EFS) was 70% (95% CI: 55-89%) and 77% (95% CI: 66-89%), respectively. Corresponding 3-year overall survival (OS) was 89% (95% CI: 77-100%) and 85% (95% CI: 75-96%), respectively (p-value not significant). EFS and OS of all 2071 patients with true localised disease were 87% (95% CI: 86-89%) and 96% (95% CI: 94-97%), respectively. Patients with metastatic disease (n = 358) had 3-year EFS and OS estimates of 68% (95% CI: 63-74%) and 77% (95% CI: 72-82%), respectively.
CONCLUSIONS: EFS and OS of patients with CT-only lung lesions were inferior to that of true localised-disease patients and superior to that of patients with metastatic disease. However, no significant difference was found in EFS and OS between CT-only patients treated for localised or metastatic disease. The clinician's preference to treat patients with CT-only pulmonary nodules as metastatic disease is not evidence-based. Chest CT at diagnosis does not improve outcome but presents paediatric oncologists with a difficult dilemma.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21703848     DOI: 10.1016/j.ejca.2011.05.025

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  16 in total

1.  Considerations in the Diagnosis and Management of Pediatric Patients With Favorable Histology Wilms Tumor Who Present With Only Pulmonary Nodules.

Authors:  Daniel M Green
Journal:  Pediatr Blood Cancer       Date:  2015-12-02       Impact factor: 3.167

2.  Omitting pulmonary radiotherapy in selected stage IV nephroblastoma patients with pulmonary metastases.

Authors:  Marry M van den Heuvel-Eibrink; Saskia L Gooskens; Filippo Spreafico
Journal:  Transl Pediatr       Date:  2013-01

Review 3.  Position paper: Rationale for the treatment of Wilms tumour in the UMBRELLA SIOP-RTSG 2016 protocol.

Authors:  Marry M van den Heuvel-Eibrink; Janna A Hol; Kathy Pritchard-Jones; Harm van Tinteren; Rhoikos Furtwängler; Arnauld C Verschuur; Gordan M Vujanic; Ivo Leuschner; Jesper Brok; Christian Rübe; Anne M Smets; Geert O Janssens; Jan Godzinski; Gema L Ramírez-Villar; Beatriz de Camargo; Heidi Segers; Paola Collini; Manfred Gessler; Christophe Bergeron; Filippo Spreafico; Norbert Graf
Journal:  Nat Rev Urol       Date:  2017-10-31       Impact factor: 14.432

4.  Treatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.

Authors:  David B Dix; Nita L Seibel; Yueh-Yun Chi; Geetika Khanna; Eric Gratias; James R Anderson; Elizabeth A Mullen; James I Geller; John A Kalapurakal; Arnold C Paulino; Elizabeth J Perlman; Peter F Ehrlich; Marcio Malogolowkin; Julie M Gastier-Foster; Elizabeth Wagner; Paul E Grundy; Conrad V Fernandez; Jeffrey S Dome
Journal:  J Clin Oncol       Date:  2018-04-16       Impact factor: 44.544

5.  Clinical significance of pulmonary nodules detected by CT and Not CXR in patients treated for favorable histology Wilms tumor on national Wilms tumor studies-4 and -5: a report from the Children's Oncology Group.

Authors:  Paul E Grundy; Daniel M Green; Astrid C Dirks; Andrea E Berendt; Norman E Breslow; James R Anderson; Jeffrey S Dome
Journal:  Pediatr Blood Cancer       Date:  2012-03-15       Impact factor: 3.167

6.  Reply to D.M. Green.

Authors:  David B Dix; Conrad V Fernandez; Yueh-Yun Chi; Lindsay A Renfro; Jeffrey S Dome Md
Journal:  J Clin Oncol       Date:  2020-01-17       Impact factor: 44.544

Review 7.  Management of Wilms Tumor: ICMR Consensus Document.

Authors:  Maya Prasad; Tushar Vora; Sandeep Agarwala; Siddharth Laskar; Brijesh Arora; Deepak Bansal; Gauri Kapoor; Girish Chinnaswamy; Venkatraman Radhakrishnan; Tanvir Kaur; G K Rath; Sameer Bakhshi
Journal:  Indian J Pediatr       Date:  2017-04-03       Impact factor: 1.967

Review 8.  Impact of the First Generation of Children's Oncology Group Clinical Trials on Clinical Practice for Wilms Tumor.

Authors:  Jeffrey S Dome; Elizabeth A Mullen; David B Dix; Eric J Gratias; Peter F Ehrlich; Najat C Daw; James I Geller; Murali Chintagumpala; Geetika Khanna; John A Kalapurakal; Lindsay A Renfro; Elizabeth J Perlman; Paul E Grundy; Conrad V Fernandez
Journal:  J Natl Compr Canc Netw       Date:  2021-08-01       Impact factor: 11.908

9.  Detection of pulmonary nodules at paediatric CT: maximum intensity projections and axial source images are complementary.

Authors:  Fleur Kilburn-Toppin; Owen J Arthurs; Angela D Tasker; Patricia A K Set
Journal:  Pediatr Radiol       Date:  2013-01-24

Review 10.  Advances in Wilms Tumor Treatment and Biology: Progress Through International Collaboration.

Authors:  Jeffrey S Dome; Norbert Graf; James I Geller; Conrad V Fernandez; Elizabeth A Mullen; Filippo Spreafico; Marry Van den Heuvel-Eibrink; Kathy Pritchard-Jones
Journal:  J Clin Oncol       Date:  2015-08-24       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.